| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022543 |
| Receipt No. | R000025979 |
| Official scientific title of the study | Development of assistive system for recording symptoms of chronic pain and investigation of pain exacerbation factors |
| Date of disclosure of the study information | 2016/08/15 |
| Last modified on | 2016/08/08 (Ver. 9) |
| Basic information | ||
| Official scientific title of the study | Development of assistive system for recording symptoms of chronic pain and investigation of pain exacerbation factors | |
| Title of the study (Brief title) | Development of assistive system for recording symptoms of chronic pain and investigation of pain exacerbation factors | |
| Region |
|
|
| Condition | ||||
| Condition | Chronic pain | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Some patients with chronic pain report that their pain is fluctuated intermittently in daily living. The exacerbation of pain is caused by various exacerbation factors, which can be classified into environmental, physiological and psychological factors. Conventional studies suggested that association between these factors and pain exacerbation. However, these studies did not pay attention to records for correlating exacerbation factors, time and patient personalities.
The purpose of this study is to develop an assistive system for recording symptoms of chronic pain in order to find the relation regarding exacerbation factors. We analyze data recorded by the system, and then elucidate both the specific exacerbation factors in each patients and the common factors in patients with chronic pain. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We implement several interfaces as a part of the assistive system for recording symptoms of chronic pain and their related data. These interfaces are composed of smart devices, input devices and wearable devices.
Primary outcome is the usability of these interfaces for integrating into the system. The usability of these interfaces is evaluated by questionnaires and interviews with participants. |
| Key secondary outcomes | The promising cause of chronic pain exacerbation factors will be analyzed after four to twelve weeks system use, by contrast with the questionnaires and the change in the other related data (e.g. atmospheric pressure). These are correlated by date and time.
Key secondary outcome is results in recording data analysis. The results are associated with the relationship between an exacerbation of pain and its factors, and between the exacerbation and the degree of environmental factor changes. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | We implement several interfaces as a part of the assistive system for recording symptoms of chronic pain and their related data. These interfaces of assistive system are composed of smart devices, input devices and wearable devices. The system will record symptoms of chronic pain and their related data which are correlated by date and time.
As a preliminary test, healthy subjects will use the system for a week and then the usability of these interfaces is evaluated by questionnaires and interviews with participants. After a preliminary test, patients will use the system for four to twelve weeks and then the usability of these interfaces is evaluated by questionnaires and interviews with participants. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Patients are required to meet the following conditions:
1. consenting to voluntary participation of the study with consent form 2. suffering from refractory chronic pain, such as neuropathic pain 3. receiving medical care in one or more of the following department of Okayama University Hospital: 3.1. Anesthesiology and Resuscitology Department 3.2. Neuropsychiatry Department (2)Healthy people are required to meet the following conditions: 1. consenting to voluntary participation of the study with consent form 2. having a mid-level educational experience, more than the average high school graduate 3. over 20 year old |
|||
| Key exclusion criteria | Patients who are unable to operate information input devices from some reasons, such as severe pain or motor disturbance, are excluded.
There is no key exclusion criteria for healthy person. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Akio Gofuku |
| Organization | Okayama University |
| Division name | Graduate School of Natural Science and Technology |
| Address | #408 Studies of Natural Science and Technology,3-1-1,Tsushimanaka,Kita-ku,Okayama-shi, Okayama,700-0082,Japan |
| TEL | 086-251-8022 |
| fukuchan@sys.okayama-u.ac.jp | |
| Public contact | |
| Name of contact person | Kenji Sato |
| Organization | Okayama University |
| Division name | Graduate School of Medicine Dentistry and Pharmaceutical Sciences |
| Address | 2-5-1, Shikatacho, Kita-ku Okayama-shi, Okayama, 700-0914, Japan |
| TEL | 086-235-7778 |
| Homepage URL | |
| tento@cc.okayama-u.ac.jp | |
| Sponsor | |
| Institute | Okayama University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025979 |